Filing Details

Accession Number:
0001562180-18-004822
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-04 18:10:59
Reporting Period:
2018-12-04
Accepted Time:
2018-12-04 18:10:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1560241 G1 Therapeutics Inc. GTHX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1184420 Seth Rudnick C/O G1 Therapeutics, Inc.
79 T.w. Alexander Drive
Research Triangle Park NC 27709
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-12-04 607 $0.39 607 No 4 M Direct
Common Stock Acquisiton 2018-12-04 9,393 $0.39 10,000 No 4 M Direct
Common Stock Disposition 2018-12-04 9,884 $39.31 116 No 4 S Direct
Common Stock Disposition 2018-12-04 116 $40.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2018-12-04 607 $0.00 607 $0.39
Common Stock Stock Options (Right to Buy) Disposition 2018-12-04 9,393 $0.00 9,393 $0.39
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2024-01-21 No 4 M Direct
7,969 2024-07-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 58,282 Indirect See Footnote
Footnotes
  1. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
  2. The price represents the weighted average price with a low of $38.99 and a high of $39.545. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.
  3. These shares are held in the Seth A. Rudnick 2014 GST Trust U/A Dated 03/01/2014 (the "Trust") for the benefit of the Reporting Person's heirs. The Reporting Person's spouse is trustee of the Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  4. All shares underlying this option have vested.